CurrentCardio
Get Weekly

Topic · page 12 of 18

Valvular & structural heart disease

Aortic, mitral and tricuspid disease, TAVI/TEER, surgical valve therapy, PFO/LAA closure

Briefs 441–480 of 696 placed here, newest publication first

Briefs in Valvular & structural heart disease

Newest publication first

  1. Eur Heart J

    Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair

    Cohort study

  2. JACC Cardiovasc Interv

    Timing and Outcomes of PCI in Conjunction With TAVR With Balloon-Expandable Valves

    Cohort study

  3. JACC Cardiovasc Interv

    Coronary Events After Transcatheter Aortic Valve Replacement: Insights From the France TAVI Registry

    Cohort study

  4. J Am Coll Cardiol

    Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients 40 to 75 Years of Age

    Cohort study

  5. JAMA

    Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial

    Randomised controlled trial

  6. Eur J Heart Fail

    Transcatheter Edge-To-Edge Repair in Severe Mitral Regurgitation Following Acute Myocardial Infarction – Aetiology-Based Analysis

    Cohort study

  7. JAMA

    Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The Tri.Fr Randomized Clinical Trial

    Randomised controlled trial

  8. JACC Cardiovasc Interv

    Initial Multicenter Experience With a Novel Self-Expanding TAVR System in Patients With Aortic Valve Stenosis

    Cohort study

  9. JACC Cardiovasc Interv

    Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions: The THIRD Multicenter Registry

    Cohort study

  10. JACC Cardiovasc Interv

    Surgical Bailout in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Incidence, Trends, and Clinical Outcomes

    Research article

  11. JACC Cardiovasc Interv

    Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Clinical Outcomes

    Cohort study

  12. JACC Cardiovasc Interv

    Incidence and Prognosis of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement for Bicuspid Aortic Stenosis

    Cohort study

  13. Eur J Heart Fail

    Registries on Transcatheter Edge-To-Edge Repair in Heart Failure: Current Evidence and Future Perspectives

    Meta-analysis

  14. JAMA Cardiol

    Cerebral Embolic Protection by Geographic Region: A Post Hoc Analysis of the PROTECTED TAVR Randomized Clinical Trial

    Secondary analysis

  15. JACC Cardiovasc Interv

    End of Life After Transcatheter Aortic Valve Replacement: A Danish Nationwide Cohort Study

    Cohort study

  16. JACC Cardiovasc Interv

    Femoral or Radial Secondary Access in TAVR: A Subanalysis From the Multicenter PULSE Registry

    Cohort study

  17. JACC Cardiovasc Interv

    Low-Gradient Severe Aortic Stenosis: Insights From the CURRENT AS Registry-2

    Cohort study

  18. Eur J Heart Fail

    Management of Acute Decompensated Valvular Heart Disease

    Meta-analysis

  19. JACC Cardiovasc Interv

    Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry

    Cohort study

  20. JACC Cardiovasc Interv

    Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy

    Cohort study

  21. JACC Cardiovasc Interv

    Mid-Term Outcomes of K-Clip Transcatheter Tricuspid Annuloplasty System in Patients With Severe Functional Tricuspid Regurgitation

    Cohort study

  22. JACC Cardiovasc Interv

    Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation

    Cohort study

  23. Lancet

    TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial

    Randomised controlled trial

  24. Eur J Heart Fail

    The Prognostic Value of the Dandel's Index in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Repair

    Cohort study

  25. JAMA Cardiol

    Trends in Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry

    Cohort study

  26. Eur J Heart Fail

    Relevance of Residual Tricuspid Regurgitation for Right Ventricular Reverse Remodelling After Tricuspid Valve Intervention in Patients with Severe Tricuspid Regurgitation and Right-Sided Heart Failure

    Cohort study

  27. JACC Cardiovasc Interv

    Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

    Cohort study

  28. JACC Cardiovasc Interv

    Outcomes and Impact of Device Iterations in Mitral Valve Transcatheter Edge-to-Edge Repair: The REPAIR Study

    Cohort study

  29. JACC Cardiovasc Interv

    1-Year Real-World Outcomes of TAVR With the Fifth-Generation Balloon-Expandable Valve in the United States

    Cohort study

  30. J Am Coll Cardiol

    Transcatheter Tricuspid Valve Replacement

    Guideline or statement

  31. Eur Heart J

    Cardiovascular magnetic resonance imaging in mitral valve disease

    Research article

  32. JACC Cardiovasc Interv

    1-Year Outcomes of Transcatheter Aortic Valve Replacement Using a Self-Expanding vs Balloon-Expandable Transcatheter Aortic Valve

    Cohort study

  33. JACC Cardiovasc Interv

    Meta-Analysis of Dedicated vs Off-Label Transcatheter Devices for Native Aortic Regurgitation

    Meta-analysis

  34. J Am Coll Cardiol

    Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

    Meta-analysis

  35. JACC Cardiovasc Imaging

    Echocardiographic Evaluation of Chronic Aortic Regurgitation: Comparison With Cardiac Magnetic Resonance and Implications for Guideline Recommendations

    Diagnostic or prognostic study

  36. JACC Cardiovasc Interv

    Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry

    Cohort study

  37. JACC Cardiovasc Interv

    Decision-Making Approach to the Treatment of Young and Low-Risk Patients With Aortic Stenosis

    Guideline or statement

  38. JACC Cardiovasc Interv

    Mitral Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation With Preserved Left Ventricular Function

    Cohort study

  39. JACC Cardiovasc Interv

    Impact of Optimal Procedural Result After Transcatheter Edge-to-Edge Tricuspid Valve Repair: Results From TRI-SPA Registry

    Cohort study

  40. N Engl J Med

    Transcatheter Valve Replacement in Severe Tricuspid Regurgitation

    Randomised controlled trial

All 696 Briefs in ExploreShowing Briefs 441–480 of 696, newest first